163 related articles for article (PubMed ID: 20335129)
1. [Analysis of Down syndrome screening by maternal serum detection in mid-pregnancy].
Liu YH; Li LF; Wu YM
Nan Fang Yi Ke Da Xue Xue Bao; 2010 Mar; 30(3):532-4, 537. PubMed ID: 20335129
[TBL] [Abstract][Full Text] [Related]
2. [Serum screening of fetal chromosome abnormality during second pregnancy trimester: results of 26,803 pregnant women in Jiangsu Province].
Hu YL;
Zhonghua Yi Xue Za Zhi; 2007 Sep; 87(35):2476-80. PubMed ID: 18067809
[TBL] [Abstract][Full Text] [Related]
3. Dimeric inhibin A as a marker for Down's syndrome in early pregnancy.
Aitken DA; Wallace EM; Crossley JA; Swanston IA; van Pareren Y; van Maarle M; Groome NP; Macri JN; Connor JM
N Engl J Med; 1996 May; 334(19):1231-6. PubMed ID: 8606718
[TBL] [Abstract][Full Text] [Related]
4. Second-trimester maternal serum screening for Down syndrome in Mainland China.
Liao C; Huang Y; Li D; Song S; Yi C; Zhou J
Prenat Diagn; 2006 Dec; 26(13):1271-2. PubMed ID: 17139699
[No Abstract] [Full Text] [Related]
5. Effectiveness of combining maternal serum alpha-fetoprotein and hCG in a second-trimester screening program for Down syndrome.
Mooney RA; Peterson CJ; French CA; Saller DN; Arvan DA
Obstet Gynecol; 1994 Aug; 84(2):298-303. PubMed ID: 7518896
[TBL] [Abstract][Full Text] [Related]
6. [AFP, uE3, beta-hCG levels applied for prenatal diagnosis of Down's syndrome].
Liao S; Wang Y; Ye G
Zhonghua Fu Chan Ke Za Zhi; 1997 Nov; 32(11):655-8. PubMed ID: 9639764
[TBL] [Abstract][Full Text] [Related]
7. First-trimester or second-trimester screening, or both, for Down's syndrome.
Malone FD; Canick JA; Ball RH; Nyberg DA; Comstock CH; Bukowski R; Berkowitz RL; Gross SJ; Dugoff L; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; Dukes K; Bianchi DW; Rudnicka AR; Hackshaw AK; Lambert-Messerlian G; Wald NJ; D'Alton ME;
N Engl J Med; 2005 Nov; 353(19):2001-11. PubMed ID: 16282175
[TBL] [Abstract][Full Text] [Related]
8. hCG and the free beta-subunit as screening tests for Down syndrome.
Knight GJ; Palomaki GE; Neveux LM; Fodor KK; Haddow JE
Prenat Diagn; 1998 Mar; 18(3):235-45. PubMed ID: 9556040
[TBL] [Abstract][Full Text] [Related]
9. [Screening by maternal serum markers for Down's syndrome].
Liu JT; Hao N; Sun NH; Wang FY; Xu YH; Gai MY; Bian XM; Yang JQ
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Apr; 25(2):156-9. PubMed ID: 12905710
[TBL] [Abstract][Full Text] [Related]
10. Contingent triple-screening for Down syndrome in the second trimester is not a cost-effective prenatal screening strategy in Mainland Chinese population.
Li DZ
Prenat Diagn; 2010 May; 30(5):493. PubMed ID: 20440741
[No Abstract] [Full Text] [Related]
11. 46,XY,i(21q) identified by maternal serum screening.
Meyers CM; Ghori S; Roberson AE; Blitzer MG; Cohen MM
Md Med J; 1997 Feb; 46(2):88-9. PubMed ID: 9029908
[TBL] [Abstract][Full Text] [Related]
12. Dual analyte screening for fetal Down syndrome in pregnant women over 35 years of age.
Cavalli P; Gnocchi E; Pennacchio A; Morrica B
Prenat Diagn; 1998 Jun; 18(6):637-8. PubMed ID: 9664616
[No Abstract] [Full Text] [Related]
13. Second-trimester maternal serum screening for Down syndrome in twin-to-twin transfusion syndrome.
Sermondade N; Dreux S; Oury JF; Muller F
Prenat Diagn; 2009 Aug; 29(8):814-5. PubMed ID: 19418465
[No Abstract] [Full Text] [Related]
14. Prenatal cytogenetic screening.
Simpson JL
Ultrasound Obstet Gynecol; 1995 Jan; 5(1):3-5. PubMed ID: 7531607
[No Abstract] [Full Text] [Related]
15. First-trimester biochemical screening for Down syndrome with the use of PAPP-A, AFP, and beta-hCG.
Casals E; Fortuny A; Grudzinskas JG; Suzuki Y; Teisner B; Comas C; Sanllehy C; Ojuel J; Borrell A; Soler A; Ballesta AM
Prenat Diagn; 1996 May; 16(5):405-10. PubMed ID: 8843997
[TBL] [Abstract][Full Text] [Related]
16. Adverse pregnancy outcomes after a false-positive second trimester serum screen for Down syndrome in Thai pregnant women.
Sritippayawan S; Vachirasrisoontra C
J Med Assoc Thai; 2005 Apr; 88(4):449-54. PubMed ID: 16146246
[TBL] [Abstract][Full Text] [Related]
17. [The prenatal diagnosis of Down's syndrome based on the biochemical screening of maternal serum markers].
Arbuzova SB; Nikolenko MI; Khlevnaia LA; Fedotova OO; Solov'eva VD; Malova SA
Tsitol Genet; 1998; 32(1):66-71. PubMed ID: 9695254
[TBL] [Abstract][Full Text] [Related]
18. First- and second-trimester screening: detection of aneuploidies other than Down syndrome.
Breathnach FM; Malone FD; Lambert-Messerlian G; Cuckle HS; Porter TF; Nyberg DA; Comstock CH; Saade GR; Berkowitz RL; Klugman S; Dugoff L; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; Tripp T; Bianchi DW; D'Alton ME;
Obstet Gynecol; 2007 Sep; 110(3):651-7. PubMed ID: 17766613
[TBL] [Abstract][Full Text] [Related]
19. Second-trimester Down syndrome maternal serum screening in twin pregnancies: impact of chorionicity.
Muller F; Dreux S; Dupoizat H; Uzan S; Dubin MF; Oury JF; Dingeon B; Dommergues M
Prenat Diagn; 2003 Apr; 23(4):331-5. PubMed ID: 12673641
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of effect of analytical imprecision in maternal serum screening for Down's syndrome.
Spencer K
Ann Clin Biochem; 2001 Jul; 38(Pt 4):413-4. PubMed ID: 11471889
[No Abstract] [Full Text] [Related]
[Next] [New Search]